- About
- Advertise / Support
- Contact
- CancerNetwork.com
- TargetedOnc.com
- OncLive.com
- OncNursingNews.com
- Terms & Conditions
- Privacy
- Do Not Sell My Information
© 2024 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
Know the Basics: Mantle Cell Lymphoma
Brielle Benyon, Assistant Managing Editor for CURE®, has been with MJH Life Sciences since 2016. She has served as an editor on both CURE and its sister publication, Oncology Nursing News. Brielle is a graduate from The College of New Jersey. Outside of work, she enjoys spending time with family and friends, CrossFit and wishing she had the grace and confidence of her toddler-aged daughter.
This infographic explains some of the basics on mantle cell lymphoma, a type of non-Hodgkin lymphoma.
While is a type of blood cancer, there are actually many subtypes of the disease that can be broken into two main categories: Hodgkin lymphoma and non-Hodgkin lymphoma. From there, diseases can be categorized even further out. For example, mantle cell lymphoma is a type of B-cell non-Hodgkin lymphoma.
Current Food and Drug Administration (FDA)-approved treatments for mantle cell lymphoma include:
- Chemotherapy
- Proteasome inhibitors
- Stem cell transplants
- Surveillance
However, new treatments, such as chimeric antigen receptor (CAR)-T cell therapy and immunotherapy, are also being explored in clinical trials, and could eventually become a promising and effective treatment for the disease.
Related Content:
